<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>11(12)</volume><submitter>Qiu HB</submitter><journal>Thoracic cancer</journal><pagination>3419-3421</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7705902</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Safety and efficacy of tislelizumab plus chemotherapy for first-line treatment of advanced esophageal squamous cell carcinoma and gastric/gastroesophageal junction adenocarcinoma.</pubmed_title><pmcid>PMC7705902</pmcid><pubmed_authors>Qiu HB</pubmed_authors></additional><is_claimable>false</is_claimable><name>Safety and efficacy of tislelizumab plus chemotherapy for first-line treatment of advanced esophageal squamous cell carcinoma and gastric/gastroesophageal junction adenocarcinoma.</name><description/><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Dec</publication><modification>2025-04-18T20:41:19.474Z</modification><creation>2025-02-18T23:31:11.494Z</creation></dates><accession>S-EPMC7705902</accession><cross_references><pubmed>33043992</pubmed><doi>10.1111/1759-7714.13690</doi></cross_references></HashMap>